Karolinska Institutet (KI) stands as one of the world’s leading medical universities. Renowned for its excellence, KI plays a pivotal role in advancing health and life sciences. It contributes to over 40% of all medical academic research conducted in Sweden. Moreover, KI provides the country’s widest array of education programs in medicine and health sciences. With an international focus and courses offered in entirely English, KI remains at the forefront of medical education and research.
Role in the project
As a valued partner in the ENT1DEP consortium, Karolinska Institutet (KI) plays a pivotal role in advancing the understanding of immune responses to enterovirus infections and vaccination. KI brings unique expertise in both in vitro and in vivo models, enabling ground-breaking insights into the intricate interactions between pancreatic islet cells, the immune system, and enteroviruses. Through the collaborative efforts in ENT1DEP, KI will contribute to the unravelling of disease processes the precede type 1 diabetes, providing novel insight that can shape future research and clinical approaches. Additionally, the studies conducted will yield valuable tools for the assessment of clinical interventions.
